# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001714899-23-000064
Filing Date
2023-04-18
Accepted
2023-04-18 16:05:47
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-04-18

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | fy22denaliannualreport.pdf | ARS | 13066506
| Complete submission text file | 0001714899-23-000064.txt |  | 17944743

Mailing Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Filer) CIK: 0001714899 (see all company filings)

EIN.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-38311 | Film No.: 23826859
SIC: 2836 Biological Products, (No Diagnostic Substances)